AACR project genie: Powering precision medicine through an international consortium

Cancer Discovery

Volumn 7, Issue 8, 2017, Pages 818-831

  Sweeney, S M ^a   Cerami, E ^a   Baras, A ^a   Pugh, T J ^a   Schultz, N ^a   Stricker, T ^a,a   Lindsay, J ^a   Del Vecchio Fitz, C ^a   Kumari, P ^a   Micheel, C ^a   Shaw, K ^a,a   Gao, J ^a   Moore, N ^a   Kandoth, C ^a   Reardon, B ^a   Lepisto, E ^a   Gardos, S ^a   Dang, K ^a   Guinney, J ^a   Omberg, L ^a   Yu, T ^a   Gross, B ^a   Heins, Z ^a   Hyman, D ^a   Rollins, B ^a,a   Sawyers, C ^a   Solit, D ^a   Schrag, D ^a   Velculescu, V ^a   Andre, F ^a   Bedard, P ^a   Levy, M ^a   Meijer, G ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN KINASE B;

AMERICAN ASSOCIATION FOR CANCER RESEARCH; AMPLICON; ARTICLE; CARCINOMA; DATA BASE; ELECTRONIC HEALTH RECORD; GENE MUTATION; GENE REARRANGEMENT; GENIE; GENOMICS; GENOTYPE; HUMAN; INFORMATION PROCESSING; MEDICAL INFORMATION; NON SMALL CELL LUNG CANCER; ORGANIZATION; PATENT; PERSONALIZED MEDICINE; STANDARDIZATION; SYNAPSE; TRANSLATIONAL RESEARCH; WHOLE GENOME SEQUENCING; FACTUAL DATABASE; GENETICS; INFORMATION DISSEMINATION; NEOPLASM;

DATABASES, FACTUAL; GENOMICS; HUMANS; INFORMATION DISSEMINATION; NEOPLASMS; PRECISION MEDICINE;

EID: 85026862883     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-17-0151     Document Type: Article

References (28)

1. Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, et al. Toward a shared vision for cancer genomic data. N Engl J Med 2016;375:1109–12.
2. Garraway LA, Verweij J, Ballman KV. Precision oncology: an overview. J Clin Oncol 2013;31:1803–5.
3. Tannock IF, Hickman JA. Limits to personalized cancer medicine. N Engl J Med 2016;375:1289–94.
4. Prasad V. Perspective: The precision-oncology illusion. Nature 2016; 537:S63.
5. Joyner MJ, Paneth N, Ioannidis JPA. What happens when under-performing big ideas in research become entrenched? JAMA 2016; 316:1355–6.
6. Shrager J, Tenenbaum JM. Rapid learning for precision oncology. Nat Rev Clin Oncol 2014;11:109–18.
7. Obermeyer Z, Ziad O, Emanuel EJ. Predicting the future — big data, machine learning, and clinical medicine. N Engl J Med 2016;375: 1216–9.
8. Siu LL, Lawler M, Haussler D, Knoppers BM, Lewin J, Vis DJ, et al. Facilitating a culture of responsible and effective sharing of cancer genome data. Nat Med 2016;22:464–71.
9. Blue Ribbon Panel report to the National Cancer Advisory Board [Internet]; 2016 [cited 2013 Nov 9]. Available from: https://www. cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/blue-ribbon-panel-report-2016.pdf
10. AACR Project GENIE Publicly Releases Large Cancer Genomic Data Set [Internet]. Available from: http://www.aacr.org/Newsroom/Pages/News-Release-Detail.aspx?ItemID=994#.WJEGZLYrJ0I
11. International Cancer Genome Consortium, Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, et al. International network of cancer genome projects. Nature 2010;464:993–8.
12. Derry JMJ, Mangravite LM, Suver C, Furia MD, Henderson D, Schil-dwachter X, et al. Developing predictive molecular maps of human disease through community-based modeling. Nat Genet 2012;44: 127–30.
13. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:l1.
14. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401–4.
15. Jones S, Anagnostou V, Lytle K, Parpart-Li S, Nesselbush M, Riley DR, et al. Personalized genomic analyses for cancer mutation discovery and interpretation. Sci Transl Med 2015;7:283ra53.
16. OncoTree [Internet]. Available from: http://www.cbioportal.org/oncotree/
17. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014;505:495–501.
18. Miao D, Van Allen EM. Genomic determinants of cancer immunotherapy. Curr Opin Immunol 2016;41:32–8.
19. Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet 2016;48: 607–16.
20. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330–7.
21. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61–70.
22. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, et al. COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res 2015;43:D805–11.
23. Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol 2016;34:155–63.
24. Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J, et al. OncoKB: a precision oncology knowledge base. JCO PO 2017 May 16 [Epub ahead of print].
25. Conley BA. Abstract IA38: NCI MATCH: a national precision medicine trial – Conception, development, and adjustment. Cancer Epidemiol Biomarkers Prev 2016;IA38.
26. Gracia D, Diego G. Institute of Medicine (IOM). The learning health-care system: workshop summary. Washington, DC: The National Academies Press; 2007. EIDON no 39. 2013.
27. Tunis S, Whicher D. The national oncologic PET registry: lessons learned for coverage with evidence development. J Am Coll Radiol 2009;6:360–5.
28. Haber DA, Velculescu VE. Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov 2014;4:650–61.